Stay updated with breaking news from Epicentrx Cy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- EpicentRx Inc. ("EpicentRx"), a late-stage biopharmaceutical company with platforms that treat and target multiple immune-mediated inflammatory...
/PRNewswire/ -- EpicentRx, a late clinical stage biopharmaceutical company with novel therapies to target cancer and inflammatory diseases, announced it will...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for...
/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for...